Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 5-membered heteroaryl carboxamide compounds for treatment of HBV

5-membered heteroaryl carboxamide compounds for treatment of HBV

US Patent 11560370 · Granted Jan 24, 2023

Estimated economic value: $1,137,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds for the treatment of kinase-dependent disorders2025
Pyridone compounds and methods of use2025
Compounds for the treatment of kinase-dependent disorders2025
Inhibitors of the myst family of lysine acetyl transferases2025
Inhibitors of the myst family of lysine acetyl transferases2025
5-membered heteroaryl carboxamide compounds for treatment of HBV2024
5-membered heteroaryl carboxamide compounds for treatment of HBV2024
5-membered heteroaryl carboxamide compounds for treatment of HBV2024
5-membered heteroaryl carboxamide compounds for treatment of HBV2024
5-membered heteroaryl carboxamide compounds for treatment of HBV2024
5-membered heteroaryl carboxamide compounds for treatment of HBV2024
Inhibitors of the MYST family of lysine acetyl transferases2024